Surgery Partners, Inc.
SGRY Nasdaq· Services-General Medical & Surgical Hospitals, Nec
Last close · Oct 26, 2026
$23.25
KIRA · Stoqly’s AI analyst, in plain words
- Surgery Partners, Inc. had $3.3B of revenue in fiscal 2025, up 6.2% on the year before. Over five years, revenue changed +12.2% a year on average.
- Its operating margin was 11.8%, up 0.6 pts: of every 100 in sales, about 12 is left after running the business.
- Surgery Partners, Inc. lost $77.9M in fiscal 2025.
- Free cash flow was $196M in fiscal 2025, 5.9% of revenue.
- Surgery Partners, Inc. owes $4.4B more than it holds in cash, about 7.8 years of operating profit.
Market cap
$3.0B
P/E
—
Revenue
$3.3B
Net income
−$77.9M
Free cash flow
$196M
Operating margin
11.8%
Surgery Partners, Inc. in 30 seconds · fiscal 2025
Are sales growing?
+6.2%
Yes. Sales grew 6.2% last year.
Does it make a profit?
−2.4%
No. It lost money last year.
Does profit turn into cash?
5.9%
Partly. 5.9% of sales ends up as free cash.
Is debt under control?
7.8x
Heavy. Repaying its debt would take 7.8 years of operating profit.
How healthy are the accounts?
5 / 8
Mixed. It passes 5 of 8 health tests.
How is the share priced?
—
No P/E: it made no profit over the last four quarters.
What Surgery Partners, Inc. does
No business description yet.
- Fiscal year ends
- December 31, 2025
- Latest annual report
- 10-K · Mar 2, 2026
- Legal name
- Surgery Partners, Inc.
- CIK
- 0001638833
Surgery Partners, Inc. · SGRY
Results and finances
The last 5 fiscal years. Amounts in USD.
| Fiscal year | FY21 | FY22 | FY23 | FY24 | FY25 |
|---|---|---|---|---|---|
| Sales and profit | |||||
| Revenue | $2.2B | $2.5B | $2.7B | $3.1B | $3.3B |
| Revenue growth | 19.6% | 14.1% | 8.0% | 13.5% | 6.2% |
| Operating margin | 13.6% | 13.6% | 12.0% | 11.2% | 11.8% |
| Net income | −$70.9M | −$54.6M | −$11.9M | −$168M | −$77.9M |
| Net margin | −3.2% | −2.2% | −0.4% | −5.4% | −2.4% |
| Diluted EPS | −$1.12 | −$0.59 | −$0.09 | −$1.33 | −$0.61 |
| Cash | |||||
| Cash from operations | $87.1M | $159M | $294M | $300M | $274M |
| Capital expenditure | $57.6M | $80.6M | $88.8M | $90.4M | $78.7M |
| Free cash flow | $29.5M | $78.2M | $205M | $210M | $196M |
| FCF margin | 1.3% | 3.1% | 7.5% | 6.7% | 5.9% |
| Share count change | 48.5% | 27.0% | 36.6% | 0.4% | 0.9% |
| Debt and strength | |||||
| Cash and short-term investments | $390M | $283M | $196M | $270M | $240M |
| Debt incl. finance leases | $3.3B | $3.2B | $3.5B | $4.2B | $4.7B |
| Shareholders' equity | $1.1B | $2.0B | $2.0B | $1.8B | $1.7B |
| Net debt / EBITDA | 7.3x | 6.4x | 7.4x | 7.8x | 7.8x |
| Current ratio | 1.8x | 1.9x | 1.7x | 1.8x | 1.9x |
| Returns and quality | |||||
| Return on capital | 7.2% | 6.3% | 7.1% | 4.6% | 6.3% |
| Return on equity | −11.8% | −3.5% | −0.6% | −8.9% | −4.4% |
| Piotroski F-score | 6 | 6 | 4 | 3 | 5 |
| Altman Z'' | 0.7 | 0.9 | 0.8 | 0.7 | 0.7 |
Insiders bought, 12 months
$0.1M
1 insider
Insiders sold, 12 months
$1.3M
6 insiders
Of sales under plans
0%
$0.0M
How to read these numbers
- Revenue:
- Total sales reported in the income statement.
- Operating margin:
- Operating income as a share of revenue.
- Net income:
- Profit after all expenses, interest and tax.
- Free cash flow:
- Cash from operations minus capital spending.
- Net debt / EBITDA:
- Years of EBITDA needed to pay off net debt. Below zero means more cash than debt.
- Return on capital:
- After-tax operating income as a share of the money invested in the business: debt plus equity, minus cash.
Surgery Partners, Inc. · SGRY
Charts and comparison
Ten years at a glance, and how it stacks up against similar companies.
Revenue
Net income
Margins, % of revenue
Cash vs debt (incl. leases)
Free cash flow
Dividends and buybacks
KIRA
At $23.25 a share, the company is worth $3.0B.
Source: SEC EDGAR XBRL filings (CIK 0001638833). Data updated October 24, 2026. For information only — not investment advice. Check the original filings before relying on any figure.